These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6499929)

  • 21. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices.
    Muramatsu M; Tamaki-Ohashi J; Usuki C; Araki H; Chaki S; Aihara H
    Eur J Pharmacol; 1988 Aug; 153(1):89-95. PubMed ID: 2975224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
    Hekmatpanah CR; Peroutka SJ
    Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
    Zazpe A; Artaiz I; Del Río J
    Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition by ketanserin and spiroperidol of 5-HT-induced myometrial contraction.
    Ichida S; Hayashi T; Terao M
    Eur J Pharmacol; 1983 Dec; 96(1-2):155-8. PubMed ID: 6662193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation.
    McLennan PL; Taylor DA
    Eur J Pharmacol; 1984 Sep; 104(3-4):313-8. PubMed ID: 6499925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus.
    Kilbinger H; Pfeuffer-Friederich I
    Br J Pharmacol; 1985 Jun; 85(2):529-39. PubMed ID: 3161573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of serotonin receptors modulating electrically-induced [3h]-norepinephrine release from isolated mammalian iris-ciliary bodies.
    Harris LC; Awe SO; Opere CA; LeDay AM; Ohia SE; Sharif NA
    J Ocul Pharmacol Ther; 2002 Aug; 18(4):339-48. PubMed ID: 12222764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of the 5-HT1A, 5-HT2 and 5-HT3 receptors in the bovine ciliary muscle.
    Lograno MD; Romano MR
    Eur J Pharmacol; 2003 Mar; 464(1):69-74. PubMed ID: 12600697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
    Williams BC; Shaikh S; Edwards CR
    J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Neuropharmacology; 1983 Jan; 22(1):123-6. PubMed ID: 6843781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-releasing effects of substituted piperazines in vitro.
    Pettibone DJ; Williams M
    Biochem Pharmacol; 1984 May; 33(9):1531-5. PubMed ID: 6610423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galanin increases potassium evoked release of [3H]5-hydroxytryptamine from rat hypothalamic synaptosomal preparations.
    Martire M; Fuxe K; Agnati LF; Pistritto G; Preziosi P
    Neurosci Lett; 1991 Jan; 122(1):87-90. PubMed ID: 1711661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CB1-cannabinoid receptors are involved in the modulation of non-synaptic [3H]serotonin release from the rat hippocampus.
    Balázsa T; Bíró J; Gullai N; Ledent C; Sperlágh B
    Neurochem Int; 2008 Jan; 52(1-2):95-102. PubMed ID: 17719142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
    Leysen JE; Gommeren W; De Clerck F
    Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
    Buczko W; Gambino MC; De Gaetano G
    Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of bretylium and guanethidine on 3H-noradrenaline and 3H-serotonin release in rat brain cortex slices.
    Schlicker E; Göthert M
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):196-204. PubMed ID: 6220681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.